The number of new graduates hired for sales rep roles increased in FY2025 after declining for five consecutive years, a…
HOME > TRENDS
TRENDS
- Development Tie-Ups with Immune Checkpoint Inhibitors Increase; to Maximize Value through Combination
March 27, 2015
- Most Global Products on Track to Clear Their FY2014 Sales Forecasts; Abilify Posting Sales of 650 Billion Yen
March 16, 2015
- Will SGLT-2 Inhibitors Catch On? Breakout Will Require Accumulation of Data
February 25, 2015
- Chugai Aims to Surpass 200 Billion Yen in Its Domestic Oncology Sales in 2015
February 13, 2015
- EFPIA Predicts Growth in Ethical Drug Market to Just 10 Trillion Yen in 2025
February 6, 2015
- Edoxaban Approved in US with Restriction on Use; Impact on Daiichi Sankyo’s Midterm Business Plan Remains Unclear
January 30, 2015
- Pneumococcal Vaccine Market Expanding with Inclusion in Publicly-Funded Vaccination Programs
January 16, 2015
- Drug Makers Continue Trial and Error Efforts to Improve Lecture Meetings
January 9, 2015
- ARBs at a Turning Point: Inroads by Generics to Lead to Gradual Decline in Sales
December 26, 2014
- Pharmacist Society Criticizes Inappropriate Phrases in Materials Used by Sales Reps, Questions Use of Misleading Terms
December 19, 2014
- Sales of Biosimilar EPO, G-CSF Growing as Awareness Increases
December 12, 2014
- Industry Insiders, Healthcare Providers Call for Greater Focus on PMS by MRs, Criticize Excessive Focus on Product Promotion
December 5, 2014
- Chugai’s Alecensa Off to a Good Start with Sales of 200 Million Yen in 1st Month
November 28, 2014
- Bayer Sets Target of 30% Growth in Group Sales in Japan within 4 Years; Success to Depend Largely on 2 Core Products
November 21, 2014
- Sales of Most Long-Listed Drugs Fall Short of Forecasts in Apr.-Sept.; Over 70% See Downward Revisions in Full-year Forecasts
November 11, 2014
- Chugai Led in Research Grants Payment in FY2013; Grants Fell Among Major Drug Makers
November 5, 2014
- Will Blopress AG Face Price War After Other Generics Debut in December?
November 5, 2014
- Topical Combination Psoriasis Treatment Dovobet Debuts; Expected to Improve Patient QOL, Medication Adherence
October 31, 2014
- Changes in Business Environment Spur Drug Makers to Reform Their Marketing Systems, Adopt Area Marketing Systems
October 22, 2014
- LEP Agents Contributing to Expansion of Oral Contraceptives Market, Growing Use of Low-Dose Pill
October 10, 2014
ページ
The traditional HR Business Partner (HRBP) model, once the gold standard for HR delivery, is undergoing a significant transformation. Many organizations, particularly in industries like pharmaceuticals, are moving towards a more agile resource model, aiming to streamline HR operations and…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…